p53 Regulates Mitochondrial Respiration

The energy that sustains cancer cells is derived preferentially from glycolysis. This metabolic change, the Warburg effect, was one of the first alterations in cancer cells recognized as conferring a survival advantage. Here, we show that p53, one of the most frequently mutated genes in cancers, modulates the balance between the utilization of respiratory and glycolytic pathways. We identify Synthesis of Cytochrome c Oxidase 2 (SCO2) as the downstream mediator of this effect in mice and human cancer cell lines. SCO2 is critical for regulating the cytochrome c oxidase (COX) complex, the major site of oxygen utilization in the eukaryotic cell. Disruption of the SCO2 gene in human cancer cells with wild-type p53 recapitulated the metabolic switch toward glycolysis that is exhibited by p53-deficient cells. That SCO2 couples p53 to mitochondrial respiration provides a possible explanation for the Warburg effect and offers new clues as to how p53 might affect aging and metabolism.

[1]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[2]  C. Prives,et al.  Unleashing the power of p53: lessons from mice and men. , 2006, Genes & development.

[3]  David Beach,et al.  Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.

[4]  C. Harris,et al.  p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.

[5]  P. Klatt,et al.  'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally , 2002, The EMBO journal.

[6]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[7]  Bruce J. Aronow,et al.  Chromatin Immunoprecipitation Assays Footprints in Glycolytic Genes by Evaluation of Myc E-box Phylogenetic Supplemental Material , 2004 .

[8]  L. Donehower,et al.  Probing p53 biological functions through the use of genetically engineered mouse models. , 2005, Mutation research.

[9]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[11]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[12]  R. Balaban,et al.  Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells. , 1983, Cancer research.

[13]  H. Osiewacz,et al.  Impact of a Disruption of a Pathway Delivering Copper to Mitochondria on Podospora anserina Metabolism and Life Span , 2004, Eukaryotic Cell.

[14]  Ø. Ellingsen,et al.  Cardiovascular Risk Factors Emerge After Artificial Selection for Low Aerobic Capacity , 2005, Science.

[15]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[16]  P. Kaplan,et al.  Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene , 1999, Nature Genetics.

[17]  O. Warburg.  On respiratory impairment in cancer cells. , 1956, Science.

[18]  C. Thompson,et al.  Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.

[19]  Han You,et al.  Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. , 2006, Genes & development.

[20]  E. Shoubridge,et al.  Cytochrome c Oxidase Deficiency , 1990, Pediatric Research.

[21]  L. Guarente,et al.  Calorie restriction, SIRT1 and metabolism: understanding longevity , 2005, Nature Reviews Molecular Cell Biology.

[22]  Robert S. Balaban,et al.  Mitochondria, Oxidants, and Aging , 2005, Cell.

[23]  G. Semenza,et al.  'The metabolism of tumours': 70 years later. , 2001, Novartis Foundation symposium.

[24]  Emanuel F Petricoin,et al.  Mitochondrial proteome: Altered cytochrome c oxidase subunit levels in prostate cancer , 2003, Proteomics.

[25]  Keshav K. Singh,et al.  Mitochondrial impairment in p53-deficient human cancer cells. , 2003, Mutagenesis.

[26]  K. Kinzler,et al.  Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells , 2001, Nature Medicine.

[27]  T. Fushiki,et al.  An adjustable-current swimming pool for the evaluation of endurance capacity of mice. , 1996, Journal of applied physiology.

[28]  K. Kinzler,et al.  Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. , 2004, Nucleic acids research.

[29]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[30]  R. Altman,et al.  Investigating hypoxic tumor physiology through gene expression patterns , 2003, Oncogene.

[31]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[32]  J. Ashby.  References and Notes , 1999 .